How Long Can Allergan Keep Valeant’s Bid at Bay?

May 12 (Bloomberg) -- Bloomberg’s Drew Armstrong examines Allergan’s rejection of Valeant’s unsolicited offer and actions by the drug maker to find a different buyer other than Valeant. He speaks on Bloomberg Television’s “Market Makers.”
'Huge Uncertainty' Surrounds Greek Debt Talks: Piccoli
48:55 - There is "huge uncertainty" surrounding current talks between the Greek government and the country's creditors, according to Wolfango Piccoli, director of research at Teneo Intelligence. He spoke in an interview with Anna Edwards and Guy Johnson on Bloomberg Television's "Countdown." Alan Higgins, chief investment officer at Coutts & Co., also participated in the discussion. (Source: Bloomberg)
  • Commodities Rout Signaling Structural Shift in Demand
  • Will Europe Get an Earnings Cycle This Year?
  • Is There an End to Oil’s Slide?